Given the recent uptick in options trading in IBB and impending earnings season, it is not surprising to see some play in leveraged ETFs that track the same Nasdaq Biotech index as IBB, and these are BIB (ProShares Ultra
Nasdaq Biotechnology, Expense Ratio 0.95%) and BIS (ProShares UltraShort Nasdaq Biotechnology, Expense Ratio 0.95%) which now have >$350 million and $64 million in AUM respectively.
iShares Nasdaq Biotechnology ETF
For more information on Street One ETF research and ETF trade execution/liquidity services, contact Paul Weisbruch at [email protected].
Street One Financial is an educational/research firm utilizing the Broker Dealer services of Precision Securities, a FINRA registered Broker/Dealer.